NGM BIOPHARMACEUTICALS INC

Profile

Company Names

NGM BIOPHARMACEUTICALS INC

Addresses

2855 CHURCHILL DR, HILLSBOROUGH, CA 94010

630 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-243-5555
650-685-6655

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$222,134,011.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2015-03-20 
$105,999,996.00 
$105,999,996.00 
$0.00 
Equity 
4
2014-10-09 
$20,710,000.00 
$60,000,000.00 
$39,290,000.00 
Equity 
3
2013-04-09 
$13,485,015.00 
$50,000,001.00 
$36,514,986.00 
Equity 
2
2010-03-10 
$55,389,000.00 
$55,664,000.00 
$275,000.00 
Equity 
1
2008-01-18 
$26,550,000.00 
$26,550,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LUIS 
 
BAYOL 
EXECUTIVE OFFICER
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  FLEXUS BIOSCIENCES, INC.
JIN-LONG 
 
CHEN 
EXECUTIVE OFFICER, DIRECTOR
NGM BIOPHARMACEUTICALS INC
DAVID 
 
GOEDDEL 
EXECUTIVE OFFICER, DIRECTOR
IGENICA INC   |  NGM BIOPHARMACEUTICALS INC   |  CONSTELLATION PHARMACEUTICALS INC   |  PELOTON THERAPEUTICS, INC.   |  NURIX, INC.   |  NEURONA THERAPEUTICS INC   |  IGENICA BIOTHERAPEUTICS, INC   |  FLX BIO, INC.   |  EXONICS THERAPEUTICS, INC.   |  SURROZEN, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  HEXAGON BIO INC.   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  NGM BIO HOLDINGS, INC.
DAVID 
V. 
GOEDDEL 
EXECUTIVE OFFICER, DIRECTOR
NGM BIOPHARMACEUTICALS INC   |  FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.
HELEN 
 
KIM 
EXECUTIVE OFFICER
TRINITY BIOSYSTEMS INC   |  NGM BIOPHARMACEUTICALS INC   |  NEOGENE THERAPEUTICS, INC.   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  RECODE THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA   |  PROTEGO BIOPHARMA, INC.
MARC 
 
LESCHLY 
DIRECTOR
NGM BIOPHARMACEUTICALS INC
MARK 
 
LESCHLY 
DIRECTOR
SLACKER INC   |  BROADLOGIC NETWORK TECHNOLOGIES INC   |  ORAMETRIX INC   |  NEPHROGENEX, INC.   |  ANACOR PHARMACEUTICALS INC   |  TAPJOY, INC.   |  COULOMB TECHNOLOGIES, INC.   |  ANACOR PHARMACEUTICALS, INC.   |  NGM BIOPHARMACEUTICALS INC   |  JUST FABULOUS, INC.   |  CHARGEPOINT, INC.   |  GREENFLY, INC.   |  MMAX INVESTMENT PARTNERS, INC.
ARTHUR 
 
LEVINSON 
DIRECTOR
AMYRIS, INC.   |  NGM BIOPHARMACEUTICALS INC
ARTHUR 
D. 
LEVINSON 
DIRECTOR
NGM BIOPHARMACEUTICALS INC
WILLIAM 
 
RIEFLIN 
EXECUTIVE OFFICER, DIRECTOR
NGM BIOPHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.   |  FLEXUS BIOSCIENCES, INC.   |  KALLYOPE, INC.   |  LYCIA THERAPEUTICS, INC.
WILLIAM 
J. 
RIEFLIN 
EXECUTIVE OFFICER, DIRECTOR
XENOPORT INC   |  NGM BIOPHARMACEUTICALS INC   |  FLX BIO, INC.   |  RAPT THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
DAVID 
 
SCHNELL 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  LUX BIOSCIENCES INC   |  NORA THERAPEUTICS, INC.   |  TRUBION PHARMACEUTICALS, INC   |  NGM BIOPHARMACEUTICALS INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SATORI PHARMACEUTICALS INC   |  ALVINE PHARMACEUTICALS INC   |  AJAX THERAPEUTICS, INC.
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
MCHENRY 
T. 
TICHENOR, JR. 
DIRECTOR
NGM BIOPHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-03-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-20 
2015-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-09 
2013-05-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-09 
2011-11-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2011-11-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2010-05-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2010-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-10 
2009-12-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-18 
2009-12-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-18 
2009-11-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#